• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际肺癌研究协会间皮瘤分期项目:即将发布的第九版胸膜间皮瘤 TNM 分类中“T”描述符修订建议。

The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.

机构信息

Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

National Centre for Asbestos Related Diseases, Medical School, University of Western Australia, Crawley, Western Australia, Australia.

出版信息

J Thorac Oncol. 2024 Sep;19(9):1310-1325. doi: 10.1016/j.jtho.2024.03.007. Epub 2024 Mar 21.

DOI:10.1016/j.jtho.2024.03.007
PMID:38521202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11380601/
Abstract

INTRODUCTION

The primary tumor (T) component in the eighth edition of pleural mesothelioma (PM) staging system is based on pleural involvement and extent of invasion. Quantitative assessment of pleural tumor has been found to be prognostic. We explored quantitative and qualitative metrics to develop recommendations for T descriptors in the upcoming ninth edition of the PM staging system.

METHODS

The International Association for the Study of Lung Cancer prospectively collected data on patients with PM. Sum of maximum pleural thickness (Psum) was recorded. Optimal combinations of Psum and eighth edition cT descriptors were assessed using recursive binary splitting algorithm, with bootstrap resampling to correct for the adaptive nature of the splitting algorithm, and validated in the eighth edition data. Overall survival (OS) was calculated by the Kaplan-Meier method and differences in OS assessed by the log-rank test.

RESULTS

Of 7338 patients submitted, 3598 were eligible for cT analysis and 1790 had Psum measurements. Recursive partitioning identified optimal cutpoints of Psum at 12 and 30 mm, which, in combination with extent of invasion, yielded four prognostic groups for OS. Fmax greater than 5 mm indicated poor prognosis. cT4 category (based on invasion) revealed similar performance to eighth edition. Three eighth edition descriptors were eliminated based on low predictive accuracy. Eighth edition pT descriptors remained valid in ninth edition analyses.

CONCLUSION

Given reproducible prognostication by Psum, size criteria will be incorporated into cT1 to T3 categories in the ninth edition. Current cT4 category and all pT descriptors will be maintained, with reclassification of fissural invasion as pT2.

摘要

简介

第八版胸膜间皮瘤(PM)分期系统中的主要肿瘤(T)成分基于胸膜受累和侵袭程度。已经发现胸膜肿瘤的定量评估具有预后意义。我们探索了定量和定性指标,以制定即将发布的第九版 PM 分期系统中 T 描述符的建议。

方法

国际肺癌研究协会前瞻性地收集了 PM 患者的数据。记录最大胸膜厚度(Psum)的总和。使用递归二分分裂算法评估 Psum 和第八版 cT 描述符的最佳组合,并通过引导重采样对分裂算法的自适应性质进行校正,然后在第八版数据中进行验证。通过 Kaplan-Meier 方法计算总生存期(OS),并通过对数秩检验评估 OS 的差异。

结果

提交的 7338 例患者中,3598 例符合 cT 分析条件,1790 例有 Psum 测量值。递归分区确定了 Psum 的最佳截断值为 12 和 30mm,与侵袭程度相结合,可将 OS 的预后分为四个组。Fmax 大于 5mm 表明预后不良。基于侵袭的 cT4 类别(基于侵袭)表现出类似的性能。基于低预测准确性,删除了三个第八版描述符。第八版 pT 描述符在第九版分析中仍然有效。

结论

鉴于 Psum 可重复预测预后,大小标准将纳入第九版 cT1 至 T3 类别。目前的 cT4 类别和所有 pT 描述符将保持不变,裂层侵犯重新分类为 pT2。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/18f135646c44/nihms-1980134-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/451892411814/nihms-1980134-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/5acf221c25e0/nihms-1980134-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/85f3b8b4aac4/nihms-1980134-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/18f135646c44/nihms-1980134-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/451892411814/nihms-1980134-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/5acf221c25e0/nihms-1980134-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/85f3b8b4aac4/nihms-1980134-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc6/11380601/18f135646c44/nihms-1980134-f0004.jpg

相似文献

1
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会间皮瘤分期项目:即将发布的第九版胸膜间皮瘤 TNM 分类中“T”描述符修订建议。
J Thorac Oncol. 2024 Sep;19(9):1310-1325. doi: 10.1016/j.jtho.2024.03.007. Epub 2024 Mar 21.
2
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the "N" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会间皮瘤分期项目:即将发布的第九版胸膜间皮瘤 TNM 分类中“N”描述符的建议。
J Thorac Oncol. 2024 Sep;19(9):1326-1338. doi: 10.1016/j.jtho.2024.05.003. Epub 2024 May 9.
3
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma.国际肺癌研究协会胸膜间皮瘤分期项目:扩展数据库以提供第九版胸膜间皮瘤 TNM 分类修订信息。
J Thorac Oncol. 2024 Aug;19(8):1242-1252. doi: 10.1016/j.jtho.2024.01.018. Epub 2024 Feb 1.
4
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Proposal for Revision of the TNM Stage Groupings in the Forthcoming (Ninth) Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会胸膜间皮瘤分期项目:对即将出版的(第九版)胸膜间皮瘤 TNM 分类中 TNM 分期分组的修订建议。
J Thorac Oncol. 2024 Sep;19(9):1339-1351. doi: 10.1016/j.jtho.2024.05.002. Epub 2024 May 9.
5
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会间皮瘤分期项目:即将出版的第九版胸膜间皮瘤 TNM 分类中 M 描述符的建议。
J Thorac Oncol. 2024 Nov;19(11):1564-1577. doi: 10.1016/j.jtho.2024.08.022. Epub 2024 Aug 23.
6
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.国际肺癌研究协会肺癌分期项目:即将出版的第九版肺癌 TNM 分类中 N 描述符修订建议。
J Thorac Oncol. 2024 May;19(5):766-785. doi: 10.1016/j.jtho.2023.10.012. Epub 2023 Oct 20.
7
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.IASLC 间皮瘤分期项目:对即将发布的第八版胸膜间皮瘤 TNM 分类中 T 描述符的修订建议。
J Thorac Oncol. 2016 Dec;11(12):2089-2099. doi: 10.1016/j.jtho.2016.08.147. Epub 2016 Sep 26.
8
Are there features that can predict the unresectability of pleural mesothelioma?是否存在能够预测胸膜间皮瘤无法切除的特征?
Eur Radiol. 2025 Feb;35(2):806-814. doi: 10.1007/s00330-024-10963-6. Epub 2024 Aug 15.
9
Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.美国癌症联合委员会第8版临床M1a期非小细胞肺癌分期描述符的长期生存情况。
Chest. 2024 Mar;165(3):725-737. doi: 10.1016/j.chest.2023.07.4220. Epub 2023 Aug 5.
10
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.国际肺癌研究协会间皮瘤分期项目:M 描述符建议和即将发布的(第八版)间皮瘤 TNM 分类中 TNM 分期分组的修订。
J Thorac Oncol. 2016 Dec;11(12):2112-2119. doi: 10.1016/j.jtho.2016.09.124. Epub 2016 Sep 28.

引用本文的文献

1
A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.一种有前景的胸膜间皮瘤预后指标:全免疫炎症值。
J Clin Med. 2025 Aug 4;14(15):5467. doi: 10.3390/jcm14155467.
2
Pleural mesothelioma.胸膜间皮瘤
Nat Rev Dis Primers. 2025 Aug 7;11(1):56. doi: 10.1038/s41572-025-00640-3.
3
A Diagnostic Approach to Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的诊断方法

本文引用的文献

1
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma.国际肺癌研究协会胸膜间皮瘤分期项目:扩展数据库以提供第九版胸膜间皮瘤 TNM 分类修订信息。
J Thorac Oncol. 2024 Aug;19(8):1242-1252. doi: 10.1016/j.jtho.2024.01.018. Epub 2024 Feb 1.
2
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.《2021年世界卫生组织胸膜肿瘤分类:自2015年分类以来的进展》
J Thorac Oncol. 2022 May;17(5):608-622. doi: 10.1016/j.jtho.2021.12.014. Epub 2022 Jan 10.
3
Pulm Ther. 2025 Jun 11. doi: 10.1007/s41030-025-00301-6.
4
ERS Congress 2024: highlights from the Thoracic Oncology Assembly.2024年欧洲呼吸学会大会:胸部肿瘤学大会亮点
ERJ Open Res. 2025 Apr 22;11(2). doi: 10.1183/23120541.01171-2024. eCollection 2025 Mar.
5
Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification.基于最新修订的第9版肿瘤-淋巴结-转移分类的胸膜间皮瘤胸膜切除术/纤维板剥脱术的手术指征
Interdiscip Cardiovasc Thorac Surg. 2024 Dec 25;40(1). doi: 10.1093/icvts/ivae223.
6
Is There a Pediatric Role for the General Thoracic Surgeon in a General Hospital? A 22-Year Single-Center Experience.综合医院的普通胸外科医生在儿科领域能发挥作用吗?一项为期22年的单中心经验。
J Clin Med. 2024 Nov 28;13(23):7231. doi: 10.3390/jcm13237231.
7
The Incidence of Distant Metastases in Patients with Pleural Mesothelioma Screened for a Multimodal Approach: How Much Staging Do We Really Need?采用多模式方法筛查的胸膜间皮瘤患者远处转移的发生率:我们究竟需要多少分期?
Cancers (Basel). 2024 May 17;16(10):1917. doi: 10.3390/cancers16101917.
Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.
将 CT 肿瘤体积和 CT 胸膜厚度纳入恶性胸膜间皮瘤的未来分期系统中。
Cancer Imaging. 2021 Aug 3;21(1):48. doi: 10.1186/s40644-021-00415-5.
4
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.一线纳武利尤单抗联合伊匹单抗治疗不可切除恶性胸膜间皮瘤(CheckMate 743):一项多中心、随机、开放标签、III 期临床试验。
Lancet. 2021 Jan 30;397(10272):375-386. doi: 10.1016/S0140-6736(20)32714-8. Epub 2021 Jan 21.
5
Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study.影像学腹膜癌症指数在恶性腹膜间皮瘤中的预后作用:全国队列研究。
Sci Rep. 2020 Aug 6;10(1):13257. doi: 10.1038/s41598-020-70044-8.
6
The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.根据第 8 版 AJCC 对日本乳腺癌患者预后的解剖分期和病理预后分期比较:单机构数据。
Breast Cancer. 2020 Nov;27(6):1137-1146. doi: 10.1007/s12282-020-01116-w. Epub 2020 May 29.
7
Malignant Mesothelioma In Situ: Clinical and Pathologic Implications.原位恶性间皮瘤:临床与病理意义
J Thorac Oncol. 2020 Jun;15(6):899-901. doi: 10.1016/j.jtho.2020.03.014. Epub 2020 Apr 16.
8
Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.恶性胸膜间皮瘤患者的定量临床分期。
J Natl Cancer Inst. 2018 Mar 1;110(3):258-264. doi: 10.1093/jnci/djx175.
9
The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.卵巢癌、输卵管癌和原发性腹膜癌的新分类及其临床意义。
Ann Oncol. 2017 Nov 1;28(suppl_8):viii8-viii12. doi: 10.1093/annonc/mdx445.
10
Volumetric assessment in malignant pleural mesothelioma.恶性胸膜间皮瘤的容积评估
Ann Transl Med. 2017 Jun;5(11):241. doi: 10.21037/atm.2017.05.23.